Campbell Alliance launches market research and analytics group

Wednesday, March 21, 2012 11:42 AM

Campbell Alliance, an inVentiv Health company and management consulting firm, has launched Encuity Research, the firm's market research and analytics subsidiary.

The launch of Encuity Research immediately follows the acquisition of SDI Health's promotional and medical audit businesses from IMS Health, which closed March 20, 2012. Financial terms of the transaction were not disclosed.

“The audit businesses acquired from IMS will be combined with our existing market research and analytics service lines to create a very robust business that will drive accelerated growth for us in the market research segment,” said Nader Naeymi-Rad, CEO, Campbell Alliance.

Encuity Research, to be based in Newton, Penn., will provide a range of services to the pharmaceutical and biotech industry in five specific areas, including: custom quantitative research and analytics; qualitative research; key opinion leader identification and mapping; and message tracking, including Rapid Recall (SM) message effectiveness studies; syndicated audits, including the Metropolitan Area Promotional Audit, which tracks promotional activity across 15 specialty therapeutic areas; and a wide range of SDI Health medical and promotional audits acquired from IMS Health.

Michael Turner, a six-year veteran with Campbell Alliance, will serve as general manager of Encuity Research. Turner formerly served as vice president of brand management at Campbell Alliance, and before that in consulting and leadership positions at Cognizant and ZS Associates.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs